Abingdon Health PLC Change of Nominated Adviser and Broker
2024年7月15日 - 3:00PM
RNS Regulatory News
RNS Number : 2758W
Abingdon Health PLC
15 July 2024
Abingdon Health
plc
("Abingdon Health" or "the Company")
Change of Nominated Adviser
and Broker
The Company announces its
Nominated Adviser and Broker has changed to Zeus
Capital Limited with immediate effect.
This change follows completion of
the acquisition by Zeus Capital Limited of the WH Ireland Capital
Markets Division (from WH Ireland Limited), announced earlier
today.
For further information please
contact:
Enquiries
|
Abingdon Health plc
|
www.abingdonhealth.com/investors/
|
|
Chris Yates, Chief Executive Officer
|
|
|
Chris Hand, Non-Executive Chairman
|
|
|
Zeus
Capital (Sole Broker and Nominated Adviser)
|
Tel: +44 (0) 20 7220 1666
|
|
Chris Fielding / Isaac
Hooper (Corporate Finance)
|
|
|
Fraser Marshall (Corporate
Broking)
|
|
The person responsible for arranging
the release of this announcement on behalf of the Company is Chris
Yates, Chief Executive Officer of the Company.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
APPFZGMNFZGGDZM
Abingdon Health (LSE:ABDX)
過去 株価チャート
から 12 2024 まで 1 2025
Abingdon Health (LSE:ABDX)
過去 株価チャート
から 1 2024 まで 1 2025
